tiprankstipranks
Astrazeneca Plc (AZN)
NASDAQ:AZN

AstraZeneca (AZN) Technical Analysis

5,916 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Astrazeneca Plc’s (AZN) Moving Averages Convergence Divergence (MACD) indicator is 2.02, suggesting Astrazeneca Plc is a Buy.
Astrazeneca Plc’s (AZN) 20-Day exponential moving average is 75.23, while Astrazeneca Plc’s (AZN) share price is $76.9, making it a Buy.
Astrazeneca Plc’s (AZN) 50-Day exponential moving average is 71.83, while Astrazeneca Plc’s (AZN) share price is $76.9, making it a Buy.

AstraZeneca (AZN) Pivot Points

May 19, 2024, 09:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
76.03
76.31
76.67
76.95
77.31
77.59
77.95
Fibonacci
76.31
76.55
76.70
76.95
77.19
77.34
77.59
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AstraZeneca (AZN) Moving Averages

May 19, 2024, 09:51 AM
Period
Simple
Exponential
MA5
77.08Sell
76.99Sell
MA10
76.92Sell
76.64Buy
MA20
75.58Buy
75.23Buy
MA50
70.66Buy
71.83Buy
MA100
68.01Buy
69.37Buy
MA200
66.68Buy
68.26Buy
Astrazeneca Plc’s (AZN) 10-Day exponential moving average is 76.64, while Astrazeneca Plc’s (AZN) share price is $76.9, making it a Buy.
Astrazeneca Plc’s (AZN) 100-Day exponential moving average is 69.37, while Astrazeneca Plc’s (AZN) share price is $76.9, making it a Buy.
Astrazeneca Plc’s (AZN) stock price is $76.9 and Astrazeneca Plc’s (AZN) 50-day simple moving average is 70.66, creating a Buy signal.
Astrazeneca Plc’s (AZN) stock price is $76.9 and Astrazeneca Plc’s (AZN) 100-day simple moving average is 68.01, creating a Buy signal.
Astrazeneca Plc’s (AZN) stock price is $76.9 and Astrazeneca Plc’s (AZN) 200-day simple moving average is 66.68, creating a Buy signal.

AstraZeneca (AZN) Technical Indicators

May 19, 2024, 09:51 AM
Name
Value
Implied Action
RSI (14)
71.01
Sell
STOCH (9,6)
57.55
Neutral
STOCHRSI (14)
65.83
Neutral
MACD (12,26)
2.02
Buy
ADX (14)
53.69
Sell
Williams %R
-39.50
Buy
CCI (14)
54.41
Neutral
ATR (14)
0.91
-
Ultimate Oscillator
47.46
Neutral
ROC
1.88
Buy
Astrazeneca Plc’s (AZN) Relative Strength Index (RSI) is 71.01, creating a Sell signal.
Astrazeneca Plc’s (AZN) Trend Strength Indicator (ADX) is 53.69, creating a Sell signal.
Astrazeneca Plc’s (AZN) Commodity Channel Index (CCI) is 54.41, creating a Neutral signal.
Astrazeneca Plc’s (AZN) Price Rate of Change (ROC) is 1.88, creating a Buy signal.

FAQ

Is AZN a Buy, Hold, or Sell?
Based on AZN’s technical indicators, AZN is a Buy.
    What is AZN’s RSI (14)?
    AZN’s RSI (14) is 71.01, which suggests AZN is a Sell.
      What is AZN’s MACD?
      AZN’s MACD is 2.02, which suggests AZN is a Buy.
        What is AZN’s 5-day moving average?
        AZN’s 5-day moving average is 77.08, which suggests AZN is a Sell.
          What is AZN’s 20-day moving average?
          AZN 20-day moving average is 75.58, which suggests AZN is a Buy.
            What is AZN’s 50-day moving average?
            AZN’s 50-day moving average is 70.66, which suggests AZN is a Buy.
              What is AZN’s 200-day moving average?
              AZN’s 200-day moving average is 66.68, which suggests AZN is a Buy.
                What is AZN’s Williams % R (14)?
                AZN’s Williams % R (14) is -39.50, which suggests AZN is a Buy.
                  What is AZN’s CCI (14)?
                  AZN’s CCI (14) is 54.41, which suggests AZN is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis